[Significance of the causative agent of infection for therapy of purulent peritonitis].
D000038:Abscess / Q000188:drug therapy; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy*; D001442:Bacteroides Infections / Q000188:drug therapy; D003015:Clostridium Infections / Q000188:drug therapy; D004359:Drug Therapy, Combination; D004927:Escherichia coli Infections / Q000188:drug therapy; D005260:Female; D006801:Humans; D008875:Middle Aged; D009070:Moxalactam / Q000627:therapeutic use; D010538:Peritonitis / Q000188:drug therapy* / Q000209:etiology
D000900:Anti-Bacterial Agents; D009070:Moxalactam
Die Bedeutung der Infektionserreger für die Therapie der eitrigen Peritonitis.